Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Angeforderte Firma
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Weiterlesen
Long hours. Stressful, not having training was hard to learn when things are constantly changing.
Was ist am positivsten an Kultur und Umgang in Ihrem Unternehmen?
People are pleasant for the most part.
Was sind einige der besten Dinge an Ihrem Team?
Ability to communicate with all departments maintaining timelines
Was braucht das Führungsteam, um besser zu werden?
Listening, not making rash/ fast decisions. Give employees time to breath,
Warum fühlen Sie sich unterbewertet und was würde Sie bei Ihrer Vergütung besser fühlen lassen?
no autonomy- creating the need to have multiple meeting- -my input and my time
Other Employee Reviews for Karyopharm Therapeutics
×